A Randomized Phase II/Phase III Study of Adjuvant Concurrent Radiation and Chemotherapy Versus Radiation Alone in Resected High-Risk Malignant Salivary Gland Tumors

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: salivary gland tumor | malignancy
  • Age: Between 18 - 100 Years
  • Gender: Male or Female

Individuals at least 18 years of age with Resected High-Risk Malignant Salivary Gland Tumors.

Individuals who have prior systemic chemotherapy or radition therapy for salivary gland malignancy will not be eligible.

Individuals with severe, active co-morbidity, or significant pre-existing hearing loss will not be eligible.

Women who are pregnant will not be eligible.

Recruitment Status

Open

Contact the research team to learn more about this study.

Fields marked with asterisk (*) are required

Please verify that you are not a bot.

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.

Volunteer Sign up

Volunteer Registry

Create your profile and be matched to research opportunities

Register Now!

Contact Us

If you need help finding a study or have any questions, please contact us at inhealth@iu.edu or by phone at (888) 264-0005.